ResearcherAC Camargo HospitalActive in the last 2 years

Rodrigo Gomes Taboada

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5674-2669; OpenAlex author ID A5076007677. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

Neoadjuvant radiotherapy after chemotherapy does not improve surgical or survival outcomes in borderline resectable pancreatic cancer. Co-author DOI 10.21037/jgo-2025-1-1018 ↗
Pancreatic Ductal Adenocarcinoma with Medullary Features and a Complete Pathological Response After Neoadjuvant FOLFIRINOX: A Case Report and Literature Review. Co-author DOI 10.1007/s12029-024-01140-5 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Tiago Cordeiro Felismino · 2 shared papers, 2025–2026 · strength 0.53
- Paper Pancreatic Ductal Adenocarcinoma with Medullary Features and a Complete Pathological Response After Neoadjuvant FOLFIRI… DOI 10.1007/s12029-024-01140-5 ↗
- Paper Neoadjuvant radiotherapy after chemotherapy does not improve surgical or survival outcomes in borderline resectable pan… DOI 10.21037/jgo-2025-1-1018 ↗
Victor Hugo Fonseca de Jesus · 1 shared paper, 2025 · strength 0.27
- Paper Pancreatic Ductal Adenocarcinoma with Medullary Features and a Complete Pathological Response After Neoadjuvant FOLFIRI… DOI 10.1007/s12029-024-01140-5 ↗
Larissa Garcia · 1 shared paper, 2026 · strength 0.26
- Paper Neoadjuvant radiotherapy after chemotherapy does not improve surgical or survival outcomes in borderline resectable pan… DOI 10.21037/jgo-2025-1-1018 ↗
Felipe José Fernández Coimbra · 1 shared paper, 2026 · strength 0.26
- Paper Neoadjuvant radiotherapy after chemotherapy does not improve surgical or survival outcomes in borderline resectable pan… DOI 10.21037/jgo-2025-1-1018 ↗
Angelo Borsarelli Carvalho Brito · 1 shared paper, 2026 · strength 0.26
- Paper Neoadjuvant radiotherapy after chemotherapy does not improve surgical or survival outcomes in borderline resectable pan… DOI 10.21037/jgo-2025-1-1018 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.